SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-134970
Filing Date
2019-05-02
Accepted
2019-05-02 16:02:39
Documents
102
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d724389d10q.htm 10-Q 1038934
2 EX-31.1 d724389dex311.htm EX-31.1 11231
3 EX-31.2 d724389dex312.htm EX-31.2 11240
4 EX-32 d724389dex32.htm EX-32 4879
  Complete submission text file 0001193125-19-134970.txt   14588409

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT teva-20190331.xml EX-101.INS 5191739
6 XBRL TAXONOMY EXTENSION SCHEMA teva-20190331.xsd EX-101.SCH 86284
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE teva-20190331_cal.xml EX-101.CAL 61699
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE teva-20190331_def.xml EX-101.DEF 560849
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE teva-20190331_lab.xml EX-101.LAB 575329
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE teva-20190331_pre.xml EX-101.PRE 598636
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-16174 | Film No.: 19791827
SIC: 2834 Pharmaceutical Preparations